Insider · CIK 0001030617
NOVARTIS PHARMA AG
Reports to the SEC for 10 companies · BASEL SWITZERLAND, V8
Transactions
4
Companies
10
Filings
3
CIK
0001030617
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-07-14 | Poseida Therapeutics, Inc.C Conversion | — |
| 2020-07-14 | Poseida Therapeutics, Inc.Series C Preferred StockC Conversion | — |
| 2014-08-05 | IDENIX PHARMACEUTICALS INCU Disposition from Tender | −$816M |
| 2000-10-06 | CHIRON CORPC Conversion | +$16.4M |
Recent filings
- 4NOVARTIS PHARMA AG0001104659-20-084106SEC(opens sec.gov)
- 4IDENIX PHARMACEUTICALS INC0001104659-14-059935SEC(opens sec.gov)
- 4CHIRON CORP0000950157-00-000613SEC(opens sec.gov)
Companies
- ALNYLAM PHARMACEUTICALS, INC.10% OwnerALNY
- Cellular Biomedicine Group, Inc.10% Owner
- CHIRON CORP10% Owner
- COCENSYS INCInsider
- HESKA CORPInsider
- IDENIX PHARMACEUTICALS INC10% Owner
- Poseida Therapeutics, Inc.10% Owner
- PRECISION BIOSCIENCES INC10% OwnerDTIL
- SIBIA NEUROSCIENCES INCInsider
- TREGA BIOSCIENCES INCInsider
Address
LICHSTRASSE 35
BASEL SWITZERLAND, V8, CH 4002